Billions of taxpayer dollars have been wasted on novel medication with poor effectiveness, while these dirt-cheap pills have been ignored, suppressed and outright criminalized. Yet the latest study proves it is far more effective than the one heralded as the gold standard. While ivermectin has been widely vilified as either useless, dangerous or both, studies have repeatedly demonstrated its usefulness against COVID-19. Most recently, a study published in the March 2022 issue of the International Journal of Infectious Diseases again found that treatment with ivermectin reduced mortality in COVID-19 patients — and to a greater degree than remdesivir. In the video above, nursing educator John Campbell, Ph.D., reviews the findings of this paper. Importantly, the researchers compared the use of ivermectin against the use of remdesivir, which is one of the few drugs recommended for use against COVID in the U.S. To compare outcomes between the two treatments, they analyzed …